Integral Health Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.76M | Hold |
600,000
| – | – | 0.62% | 44 |
|
|
2025
Q1 | $6.05M | Buy |
+600,000
| New | +$6.05M | 0.64% | 43 |
|
|
2024
Q3 | – | Sell |
-400,000
| Closed | -$4.23M | – | 92 |
|
|
2024
Q2 | $4.23M | Sell |
400,000
-200,000
| -33% | -$2.11M | 0.4% | 55 |
|
|
2024
Q1 | $6.32M | Buy |
+600,000
| New | +$6.32M | 0.59% | 57 |
|
|
2023
Q4 | – | Sell |
-450,000
| Closed | -$5.26M | – | 86 |
|
|
2023
Q3 | $5.26M | Buy |
+450,000
| New | +$5.26M | 0.73% | 47 |
|